Cadila Pharmaceuticals

Company commemorates centenary of founder and recalls his role in building India’s pharma manufacturing base

The new fixed-dose combination of Desloratadine and Montelukast aims to support patients with respiratory and skin-related…

Cadila Pharmaceuticals, one of India’s research-driven pharmaceutical companies, has launched Nu Nutridac, a clinically proven…

Bilacad Dex Syrup is a triple-action formula for comprehensive respiratory relief

Clinical trials have consistently shown empagliflozin’s efficacy in reducing cardiovascular mortality, heart failure…

The first panel discussion at Ahmedabad Pharma Summit 2025 was on ‘Next-gen Pharma Innovation.’ The session delved into the…

ThRabis rollout sees increased vaccine compliance and reduced treatment burden across multiple regions

Reformulated Vasograin EC manufactured in USFDA-approved facility; retains leading position in ergotamine segment

Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the…

Cadila Pharmaceuticals expands its warehouse facility to enhance operational efficiency, streamline logistics, and support growing…